What factors should influence choice of first line therapies in IBD?

08/15/2018

Related Content

Medication Prescribing
Cohen head shot
Medication Prescribing
Russell Cohen, MD, on Positioning Biosimilars in IBD
07/30/2020
Dr Cohen reviews his presentation from the July 25 AIBD regional meeting on using biosimilars as first-line and switch therapy in patients with inflammatory bowel disease.
07/30/2020
Gastroenterology
aibd
Gastroenterology
How can we better prevent and treat narcotic dependence in our pediatric IBD patients?
08/15/2018
08/15/2018
Nutrition
lempert
Nutrition
Two Views of What USDA Should Be
12/16/2020
Ricardo Salvador, director of the Food & Environment program at the Union of Concerned Scientists and Mark Bittman, cookbook author extraordinare and former NY Times columnist co-wrote an engaging and...
12/16/2020
Gastroenterology
video
Gastroenterology
What are the risks of malignancies due to having IBD and being on immunomodulators and/or biologics: How can we help our patients avoid those risks?
08/07/2018
08/07/2018
Gastroenterology
ddw
Gastroenterology
Expert Perspectives: The Evolution of Personalized IBD Care
08/16/2018
08/16/2018